​

Natera (NTRA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

NTRA Stock Forecast

Natera (NTRA) stock forecast, based on 27 Wall Street analysts, predicts a 12-month average price target of $263.78, with a high of $285.00 and a low of $220.00. This represents a 32.46% increase from the last price of $199.14.

$50 $100 $150 $200 $250 $300 High: $285 Avg: $263.78 Low: $220 Last Closed Price: $199.14

NTRA Stock Rating

Natera stock's rating consensus is Buy, based on 27 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 25 Buy (92.59%), 2 Hold (7.41%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 27 0 2 25 Strong Sell Sell Hold Buy Strong Buy

NTRA Price Target Upside V Benchmarks

TypeNameUpside
StockNatera32.46%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks33.38%

Price Target Trends

1M3M12M
# Anlaysts4414
Avg Price Target$251.00$251.00$242.07
Last Closing Price$199.14$199.14$199.14
Upside/Downside26.04%26.04%21.56%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
May, 264132--19
Apr, 265122--19
Mar, 265132--20
Feb, 265132--20
Jan, 265122--19
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 12, 2026Piper Sandler$249.00$199.1425.04%25.04%
May 08, 2026Robert W. Baird$265.00$201.1331.76%33.07%
May 08, 2026Evercore ISI$270.00$200.2034.87%35.58%
May 08, 2026Brandon CouillardWells Fargo$220.00$219.820.08%10.48%
Jan 05, 2026Guggenheim$270.00$230.6517.06%35.58%
Dec 22, 2025Canaccord Genuity$285.00$231.9622.87%43.12%
Dec 15, 2025Wells Fargo$205.00$231.88-11.59%2.94%
Dec 15, 2025Barclays$270.00$231.8816.44%35.58%
Dec 01, 2025Morgan Stanley$265.00$234.2513.13%33.07%
Nov 18, 2025UBS$280.00$213.6531.06%40.60%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 12, 2026Piper SandlerOverweightOverweighthold
May 08, 2026Evercore ISIOutperformOutperformhold
Apr 14, 2026William BlairOutperforminitialise
Jan 12, 2026Canaccord GenuityBuyBuyhold
Jan 07, 2026Cowen & Co.BuyBuyhold
Jan 07, 2026CitigroupBuyinitialise
Jan 05, 2026GuggenheimBuyBuyhold
Dec 15, 2025BarclaysOverweightOverweighthold
Dec 11, 2025Cowen & Co.BuyBuyupgrade
Oct 27, 2025Exane BNP ParibasNeutralupgrade

Financial Forecast

EPS Forecast

$-6 $-5 $-4 $-3 $-2 $-1 $0 $1 $2 $3 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-5.21$-5.57$-3.78$-1.53$-1.52---
Avg Forecast$-5.02$-5.60$-3.96$-1.50$-1.20$0.02$0.98$1.46
High Forecast$-4.90$-5.26$-3.87$-1.22$-0.79$0.37$2.21$1.53
Low Forecast$-5.32$-5.85$-4.05$-1.61$-1.51$-0.15$0.18$1.33
Surprise %3.78%-0.54%-4.55%2.00%26.67%---

Revenue Forecast

$500M $1B $2B $2B $3B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$625.49M$820.22M$1.08B$1.70B$2.31B---
Avg Forecast$621.43M$819.43M$1.07B$1.65B$1.82B$2.14B$2.46B$2.68B
High Forecast$650.44M$846.85M$1.09B$1.66B$1.88B$2.15B$2.46B$2.79B
Low Forecast$610.12M$780.38M$1.06B$1.64B$1.78B$2.14B$2.45B$2.50B
Surprise %0.65%0.10%1.17%2.72%26.80%---

Net Income Forecast

$-600M $-420M $-240M $-60M $120M $300M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-471.72M$-547.80M$-434.80M$-190.43M$-208.16M---
Avg Forecast$-398.29M$-395.34M$-499.34M$-162.83M$-145.21M$33.61M$168.67M$167.89M
High Forecast$-318.63M$-316.27M$-399.47M$-140.20M$-90.38M$42.22M$253.93M$176.39M
Low Forecast$-477.94M$-474.40M$-599.21M$-185.46M$-173.31M$-17.72M$20.83M$152.77M
Surprise %18.44%38.57%-12.93%16.95%43.35%---

NTRA Forecast FAQ

Is Natera stock a buy?

Natera stock has a consensus rating of Buy, based on 27 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 25 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Natera is a favorable investment for most analysts.

What is Natera's price target?

Natera's price target, set by 27 Wall Street analysts, averages $263.78 over the next 12 months. The price target range spans from $220 at the low end to $285 at the high end, suggesting a potential 32.46% change from the previous closing price of $199.14.

How does Natera stock forecast compare to its benchmarks?

Natera's stock forecast shows a 32.46% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the diagnostics & research stocks industry (33.38%).

What is the breakdown of analyst ratings for Natera over the past three months?

  • May 2026: 21.05% Strong Buy, 68.42% Buy, 10.53% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 26.32% Strong Buy, 63.16% Buy, 10.53% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 25.00% Strong Buy, 65.00% Buy, 10.00% Hold, 0% Sell, 0% Strong Sell.

What is Natera’s EPS forecast?

Natera's average annual EPS forecast for its fiscal year ending in December 2026 is $0.02, marking a -101.32% decrease from the reported $-1.52 in 2025. Estimates for the following years are $0.98 in 2027, and $1.46 in 2028.

What is Natera’s revenue forecast?

Natera's average annual revenue forecast for its fiscal year ending in December 2026 is $2.14B, reflecting a -7.05% decrease from the reported $2.31B in 2025. The forecast for 2027 is $2.46B, and $2.68B for 2028.

What is Natera’s net income forecast?

Natera's net income forecast for the fiscal year ending in December 2026 stands at $33.61M, representing a -116.14% decrease from the reported $-208M in 2025. Projections indicate $168.67M in 2027, and $167.89M in 2028.